At the genetic component level, different studies reveal the importance of the polymorphic variant of clock genes (see Table 3) and how the Chrono-type modulates the risk of cancer, such as observed in breast cancer, in which the risk is more elevated in premenopausal women (OR, 2.43 and 2.55; resp). The gene discussed is CLOCK; the disease is breast cancer.